Alder BioPharmaceuticals reports fourth quarter and year-end 2014 financial results
Alder reported total revenues of $54.7 million For the full year 2014 compared to $18.8 million in 2013. Net income for the full year 2014 totaled $8.9 million compared to a net loss of $20.6 million in 2013. As of Dec. 31, 2014, Alder had $55.9 million in cash and equivalents. March 04, 2015